File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Parathyroid Cancer

TitleParathyroid Cancer
Authors
Issue Date2006
PublisherWB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/
Citation
Surgical Oncology Clinics of North America, 2006, v. 15 n. 3, p. 573-584 How to Cite?
AbstractParathyroid cancer is a rare endocrine tumor and an uncommon cause of HPT. Advances have been made to identify a promising molecular diagnostic marker for the disease. The use of accurate preoperative imaging modalities would undoubtedly facilitate its management by making an accurate preoperative diagnosis by assessing its invasiveness, and by searching for nodal or distant metastases. The effectiveness of the application of intraoperative PTH assay in the management of this rare condition remains to be seen. Radical surgical treatment offers the best chance of cure, but for patients who have refractory unresectable disease or metastases, the availability of more effective targeted medical therapy may palliate the debilitating symptoms of hypercalcemia, reduce its metabolic complications, and potentially improve survival.
Persistent Identifierhttp://hdl.handle.net/10722/192072
ISSN
2015 Impact Factor: 1.958
2015 SCImago Journal Rankings: 0.859
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLang, B-
dc.contributor.authorLo, CY-
dc.date.accessioned2013-10-17T02:08:13Z-
dc.date.available2013-10-17T02:08:13Z-
dc.date.issued2006-
dc.identifier.citationSurgical Oncology Clinics of North America, 2006, v. 15 n. 3, p. 573-584-
dc.identifier.issn1055-3207-
dc.identifier.urihttp://hdl.handle.net/10722/192072-
dc.description.abstractParathyroid cancer is a rare endocrine tumor and an uncommon cause of HPT. Advances have been made to identify a promising molecular diagnostic marker for the disease. The use of accurate preoperative imaging modalities would undoubtedly facilitate its management by making an accurate preoperative diagnosis by assessing its invasiveness, and by searching for nodal or distant metastases. The effectiveness of the application of intraoperative PTH assay in the management of this rare condition remains to be seen. Radical surgical treatment offers the best chance of cure, but for patients who have refractory unresectable disease or metastases, the availability of more effective targeted medical therapy may palliate the debilitating symptoms of hypercalcemia, reduce its metabolic complications, and potentially improve survival.-
dc.languageeng-
dc.publisherWB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/-
dc.relation.ispartofSurgical Oncology Clinics of North America-
dc.subject.meshParathyroid Hormone - blood-
dc.subject.meshParathyroid Neoplasms - complications - diagnosis - surgery-
dc.subject.meshParathyroidectomy-
dc.subject.meshRadiopharmaceuticals - diagnostic use-
dc.subject.meshTechnetium Tc 99m Sestamibi - diagnostic use-
dc.titleParathyroid Canceren_US
dc.typeArticleen_US
dc.identifier.emailLang, B: blang@hkucc.hku.hk-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.soc.2006.05.003-
dc.identifier.pmid16882498-
dc.identifier.scopuseid_2-s2.0-33746352806-
dc.identifier.hkuros117641-
dc.identifier.volume15-
dc.identifier.issue3-
dc.identifier.spage573-
dc.identifier.epage584-
dc.identifier.isiWOS:000241758000009-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats